Daniel, Jacinta .
HRN: 02-18-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2025
CEFTRIAXONE 1G (VIAL)
10/31/2025
11/06/2025
IV
2g
Od
Typhoid Fever
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes